Abbott Laboratories (NYSE:ABT)

59.12
Delayed Data
As of 4:01pm ET
 -1.05 / -1.75%
Today’s Change
42.31
Today|||52-Week Range
64.60
+3.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Operating ActivitiesNet Income / Starting Line419.0M283.0M603.0M--
 
 
 
 
Depreciation774.0M648.0M756.0M--
 
 
 
 
Total Other Cash Flow563.0M522.0M93.0M--
 
 
 
 
Funds From Operations1.8B1.5B1.5B--
 
 
 
 
Extraordinary Items-1.2B0.00-12.0M--
 
 
 
Funds From/For Other Operating Expenses31.0M102.0M-565.0M--
 
 
 
 
Net Cash Flow - Operating Activities574.0M1.4B2.0B--
 
 
 
 
 
InvestingIncrease In Investments-15.0M-13.0M-70.0M--
 
 
 
 
Decrease In Investments1.7B239.0M53.0M--
 
 
 
 
Capital Expenditures-272.0M-255.0M-263.0M--
 
 
 
 
Fixed Asset Disposal5.5B-1.0M-29.0M--
 
 
 
 
Net Assets From Acquisitions -13.0B0.000.00--
 
 
Other Investing - Sources3.0M24.0M3.0M--
 
 
 
 
Net Cash Flow Investing-6.2B-6.0M-306.0M--
 
 
 
 
 
FinancingShort Term Borrowings-1.5B26.0M5.0M--
 
 
 
 
Long Term Borrowings0.000.00-8.0M--
 
 
Long Term Debt Reduction-2.5B-2.0M-1.0M--
 
 
 
 
Net Proceeds Stock Sale129.0M57.0M89.0M--
 
 
 
 
Common Preferred Redeemed-95.0M-3.0M-8.0M--
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-460.0M-462.0M-463.0M--
 
 
 
 
Other Sources - Financing----------
Other Uses - Financing13.0M0.000.00--
 
 
Net Cash Flow - Financing-4.4B-384.0M-386.0M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash65.0M8.0M24.0M--
 
 
 
 
 
Net Change In Cash-10.0B961.0M1.3B0.00